Fundraising Fox

Biolinq

134 employees on LinkedIn · 9 known investors

Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device. It uses an on-device LED light system to signal glucose levels in real time and pairs with a mobile app that provides personalized health insights and trend tracking.

Digital HealthHardwareMedical Devices

Founders & leadership

JTJared Tangney
Jared TangneyinFounder
RYRich Yang
Rich YanginFounder

Investors · 9

Able PartnersNew York · $500K – $3M
Alpha Wave GlobalMiami
Aphelion Capital
Averin CapitalNew York
BOLD LongevityBoston
Hikma VenturesLondon · $5M
M VenturesLos Angeles · $10.8M
RiverVest Venture PartnersSt. Louis · $500K – $3M
LifeSci Venture PartnersreportedNew York

Funding

SEC filings, press & company announcements

$100M disclosed across 1 of 3 rounds · 2024–2025

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Biolinq went on to found or lead other companies.

Buddha ChaudhuriSenior Microfabrication EngineerFounded KeylikaAlbert CaiSenior Regulatory Affairs SpecialistFounded Harbor

In the news

FDA clears Biolinq's color-coded sensor patch for glucose rangesfiercebiotech.com · Sep 2025Biolinq raises $100m for intradermal glucose sensor - Desang Diabetes Servicesdesang.net · May 2025Biolinq Lands $100M Series C - San Diego Business Journalsdbj.com · Apr 2025Biolinq Raises $100Mn in Series C Funding for Wearable Glucose Sensorsdigitalhealthnews.com · Apr 2025Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health - BioSpacebiospace.com · Apr 2025Biolinq Raises $58M in Fundingfinsmes.com · Apr 2024

Frequently asked questions

What does Biolinq do?
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device. It uses an on-device LED light system to signal glucose levels in real time and pairs with a mobile app that provides personalized health insights and trend tracking.
Who founded Biolinq?
Biolinq was founded by Jared Tangney.
Who are Biolinq's investors?
Biolinq's investors include Able Partners, Alpha Wave Global, Aphelion Capital, Averin Capital, BOLD Longevity, Hikma Ventures, M Ventures, RiverVest Venture Partners and 1 more.
How much funding has Biolinq raised?
Biolinq has disclosed $100M raised across 1 of its 3 known rounds.